The analysis of China's compression atomizer industry

Views : 14
Author : Joe Wong
Update time : 2020-10-02 14:18:39
The analysis of China's compression atomizer industry 

The nebulizer consists of a host, a connecting device, an atomizing device, and an inhalation device. It atomizes the liquid medicine into tiny particles, and the medicine enters the respiratory tract and lungs through breathing inhalation to achieve rapid and effective treatment of colds, coughs, asthma, Pharyngitis, rhinitis, bronchitis and other respiratory diseases.

 From the perspective of technology, in medicine, the ultrasonic atomizer is called the first generation atomizer, the compression atomizer is called the second generation atomizer, and the mesh atomizer is the third generation atomizer. These three generations of products present Three stages of development of the atomizer.

Atomizer technology history

The compressed nebulizer has the advantages of fine and uniform drug particles, easy to penetrate into the lungs and bronchial blood vessels through breathing, and less dosage, suitable for direct absorption by the human body, speeding up the arrival of drugs to the affected area, and long service life. It is gradually replacing the ultrasonic nebulizer.

With the expansion of the market size of the compression atomizer industry, the number of companies in the industry has also increased significantly. my country's compression atomizer production technology is mature, the production capacity is huge, and it has a large cost advantage. It is one of the most important producers and exporters in the world. According to incomplete statistics, there are currently about 135 valid domestic-made compression atomizer registration approvals in my country. The number of registration approvals from 2014 to 2019 has shown a significant upward trend, reaching 32 in 2019. The supply of products in the industry has become more adequate and market competition has become more intense.

The main brands of my country's compression atomizer market include Yuyue, Barry, Omron, Sean, Fulin, Debai, etc., among which domestic brands have a higher overall proportion, and the manufacturers are mainly located in Jiangsu and Zhejiang.

 In 2015, the output of my country's compression atomizer industry was about 2.55 million units, which increased to 9.35 million units in 2019.

The compression atomizer industry is a sub-industry of the medical device industry. At present, chronic respiratory diseases represented by asthma in my country are showing a trend of increasing incidence. In the treatment of respiratory diseases, nebulized inhalation therapy treats diseases by atomizing the drug into inhalable particles and depositing the drug in the lower respiratory tract. This method directly acts on the diseased area. Compared with the oral method, it has a small dosage, rapid onset, and rapid effect. The advantages of good treatment effect, few systemic adverse reactions, and easy cooperation of patients have been unanimously recommended by medical guidelines at home and abroad, and have been widely used in large cities in my country. At the same time, with the growth of residents’ income and the increase in health awareness, the demand for more excellent atomizer products such as compression atomizers continues to rise. In 2015, the sales volume of my country's compression atomizer industry was about 500,000 units, and it will increase by 2019. To 4.8 million units.

According to the "Analysis of China's Aluminum Aerosol Can Industry Operation Status and Future Investment Prospects Report from 2020-2026" released by Zhiyan Consulting, the domestic demand for compressed atomizers has grown rapidly with the continuous improvement of the domestic economy. From 240 million yuan in 2015 to 1.44 billion yuan in 2019.

Compression nebulizers still have great potential in the domestic market, and the penetration rate of compression nebulizers in the treatment of chronic respiratory diseases is still very low. It will take some time for the compression atomizer to reach its peak in China, and it has become a must-have product for many families abroad. It is believed that in the near future, the compression atomizer will be used by more and more Chinese Accept it and become another new member of family healthcare.

The integration of the compression atomizer industry is gradually accelerating. In the field of production, thanks to the implementation of the country’s policy of encouraging innovation and import substitution, domestic enterprises have ushered in development opportunities. In order to seize the opportunities, leading domestic companies have stepped up their layouts and focused on In the subdivided areas, we will be more sophisticated and specialized, and there are also those who lay out the entire industrial chain to become bigger and stronger.

Chinese companies have localized talents who understand the national conditions and relevant policies and regulations better; they also understand the Chinese market better. Chinese compressed atomizer companies are flexible in operation and have a relative advantage in cost price. In the process of manufacturing and operating conventional equipment, they have a better cost-effective advantage. In the future, it will continue to develop. Domestically produced compression atomizer products have comprehensive market competitive advantages. It is expected that the concentration of the compression atomizer industry will increase significantly in the future.